微創脊椎設備市場:開發平台報告(開發階段,市場區隔,地區·國家,法規途徑,主要企業等),2023年最新版
市場調查報告書
商品編碼
1345181

微創脊椎設備市場:開發平台報告(開發階段,市場區隔,地區·國家,法規途徑,主要企業等),2023年最新版

Minimal Invasive Spinal Devices Pipeline Report Including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

出版日期: | 出版商: GlobalData | 英文 | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

微創脊柱融合術 (MIS) 使用空心螺釘和非空心螺釘等裝置來穩定椎骨和關節。

本報告提供微創脊椎設備市場相關調查,提供產品概要與正在開發的開發中產品趨勢,各種處於開發階段產品的比較分析和進行中的臨床試驗相關資訊,參與企業的最近趨勢等資訊。

目錄

第1章 目錄

第2章 簡介

  • 微創脊椎設備概要

第3章 開發中的產品

  • 微創脊椎設備- 各開發階段平台產品
  • 微創脊椎設備- 各市場區隔開發中產品
  • 微創脊椎設備- 各地區開發中產品
  • 微創脊椎設備- 各法規途徑開發中產品
  • 微創脊椎設備- 各估計核准日開發中產品
  • 微創脊椎設備- 進行中的臨床試驗

第4章 微創脊椎設備- 企業正在開發的開發中產品

  • 微創脊椎設備企業- 各開發階段平台產品
  • 微創脊椎設備- 各開發階段平台產品

第5章 微創脊椎設備的企業和產品概要

第6章 微創脊椎設備- 最近的開發

  • 2023 年 7 月 5 日:Inspired Spine 在德國舉辦第三個國際實驗室,展示 OLLIF 和 Trident SI 聯合融合程序
  • 2023年5月23日:Aurora Spine計劃發布2023財年第一季度財務業績和電話會議
  • 2023 年 4 月 26 日:Aurora Spine 計劃發布第四季度和 2022 財年財務業績和電話會議
  • 2023 年 2 月 16 日:Lazurite 任命醫生加入醫療諮詢委員會
  • 2022 年 11 月 21 日:Aurora Spine 公佈 2022 年第三季度財務業績
  • 2022年10月12日:奧羅拉脊柱公司將出席北美脊柱學會年會

第7章 附錄

  • 調查手法
  • 關於GlobalData
  • 詢問
  • 免責聲明
Product Code: GDME1608EPD

Abstract

GlobalData's Medical Devices sector report, "Minimal Invasive Spinal Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Minimal Invasive Spinal Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Minimally Invasive Spine (MIS) fusion surgery is performed to stabilize the vertebral bones and joints using devices such as Cannulated and non-Cannulated screws.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Minimal Invasive Spinal Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Minimal Invasive Spinal Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Minimal Invasive Spinal Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Minimal Invasive Spinal Devices Overview

3 Products under Development

  • 3.1 Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • 3.2 Minimal Invasive Spinal Devices - Pipeline Products by Segment
  • 3.3 Minimal Invasive Spinal Devices - Pipeline Products by Territory
  • 3.4 Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
  • 3.5 Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
  • 3.6 Minimal Invasive Spinal Devices - Ongoing Clinical Trials

4 Minimal Invasive Spinal Devices - Pipeline Products under Development by Companies

  • 4.1 Minimal Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development

5 Minimal Invasive Spinal Devices Companies and Product Overview

6 Minimal Invasive Spinal Devices- Recent Developments

  • 6.1 Jul 05, 2023: Inspired Spine Hosts Third International Lab in Germany, Showcasing OLLIF and Trident SI Joint Fusion Procedures
  • 6.2 May 23, 2023: Aurora Spine schedules release of Q1 fiscal year 2023 financial results and conference call
  • 6.3 Apr 26, 2023: Aurora Spine schedules release of Q4 and fiscal year 2022 financial results and conference call
  • 6.4 Feb 16, 2023: Lazurite Names Physicians to Medical Advisory Board
  • 6.5 Nov 21, 2022: Aurora Spine Announces Third Quarter Fiscal 2022 Financial Results
  • 6.6 Oct 12, 2022: Aurora Spine Corporation to Attend the North American Spine Society Annual Meeting

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • Minimal Invasive Spinal Devices - Pipeline Products by Segment
  • Minimal Invasive Spinal Devices - Pipeline Products by Territory
  • Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
  • Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
  • Minimal Invasive Spinal Devices - Ongoing Clinical Trials
  • Minimal Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
  • Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Minimal Invasive Spinal Devices - Pipeline Products by Stage of Development
  • Minimal Invasive Spinal Devices - Pipeline Products by Segment
  • Minimal Invasive Spinal Devices - Pipeline Products by Territory
  • Minimal Invasive Spinal Devices - Pipeline Products by Regulatory Path
  • Minimal Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
  • Minimal Invasive Spinal Devices - Ongoing Clinical Trials